Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.

Personal Genome Diagnostics (PGDx), a US-based cancer diagnostics developer spun out of Johns Hopkins University, secured $103m yesterday in a series C round led by investment firm Cowen Healthcare Investments. PFM Health Sciences, Rock Springs Capital, Sands Capital, Vensana Capital, Windham Ventures, Catalio Capital Management, Innovatus Capital Partners, Kern Capital, New Enterprise Associates (NEA) and…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.